Insider Shareholders with Direct Ownership of Century Therapeutics, Inc. (IPSC)
This section provides a comprehensive overview of the insiders with direct ownership of Century Therapeutics, Inc. (IPSC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Century Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Aktiengesellschaft Bayer
> 10% Shareholder |
12,675,838 | 0 | 12,675,838 $16 Million | 1 |
Jun 22, 2021
Added 5.59%
|
|
Versant Venture Capital Vi, L.P.
> 10% Shareholder |
9,936,011 | 1,464,800 | 11,452,014 $14.4 Million | 4 |
Aug 09, 2022
Reduced 3.09%
|
|
Fujifilm Cellular Dynamics, Inc.
> 10% Shareholder |
3,974,404 | 0 | 6,955,207 $8.76 Million | 1 |
Jun 22, 2021
Added 36.36%
|
|
Brent Pfeiffenberger
President and CEO |
1,470,704 | 0 | 1,470,704 $1.85 Million | 2 |
Mar 07, 2024
Added 1.17%
|
|
Douglas Carr
SVP Finance & Operations |
166,853 | 35,251 | 317,147 $399,605 | 11 |
Nov 04, 2024
Reduced 0.09%
|
|
Gregory Russotti
Officer |
24,000 | 27,386 | 274,933 $346,415 | 9 |
Jul 26, 2024
Reduced 0.21%
|
|
Luis Borges
Chief Scientific Officer |
401,446 | 144,911 | 256,535 $323,234 | 8 |
Apr 03, 2023
Added 2.82%
|
|
Michael Craig Diem
Chief Financial Officer |
194,808 | 20,763 | 253,533 $319,451 | 3 |
Nov 01, 2023
Reduced 7.57%
|
|
Chad Cowan
Chief Scientific Officer |
74,376 | 0 | 210,806 $265,615 | 1 |
Oct 01, 2024
Added 26.08%
|
|
Adrienne Farid
Chief Operations Officer |
121,750 | 60,838 | 135,130 $170,263 | 12 |
Nov 04, 2024
Reduced 0.76%
|
|
Morgan Conn
Chief Finanical Officer |
60,148 | 0 | 60,148 $75,786 | 1 |
Oct 14, 2024
Added 50.0%
|
|
Hyam Levitsky
President of R&D |
24,000 | 0 | 24,000 $30,240 | 1 |
Mar 07, 2024
Added 50.0%
|
|
Daphne Quimi
Director |
5,000 | 0 | 5,000 $6,300 | 1 |
Sep 12, 2024
Added 50.0%
|